Related Experiment Video
Updated: Oct 1, 2025

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
Published on: August 7, 2017
Structural (dys)connectivity associates with cholinergic cell density in Alzheimer's disease
Chen Pei Lin1, Irene Frigerio1, Baayla D C Boon2,3
1Amsterdam UMC, Location VUmc, Vrije Universiteit Amsterdam, Department of Anatomy and Neurosciences, Amsterdam Neuroscience, Amsterdam, The Netherlands.
Alzheimer's disease causes memory loss by damaging the nucleus basalis of Meynert, a key brain region. This study links this degeneration to reduced integrity of its connections to the temporal lobe.
Area of Science:
- Neuroscience
- Neuropathology
- Neuroimaging
Background:
- Cognitive deficits in Alzheimer's disease (AD) are linked to cholinergic system degeneration.
- The nucleus basalis of Meynert (NBM) in the basal forebrain is central to this cholinergic system.
- NBM atrophy and altered tract integrity are observed in AD.
Purpose of the Study:
- To investigate the pathophysiology of NBM atrophy and its neocortical projections in AD.
- To correlate in situ MRI findings with histopathology in AD brains.
Main Methods:
- Combined post-mortem in situ MRI (T1-weighted and diffusion-weighted imaging) and histopathology.
- Analysis of NBM volume, microstructural integrity, and cholinergic cell density.
- Immunohistochemistry for amyloid-β, phosphorylated-tau, and choline acetyltransferase.
Main Results:
- AD donors showed reduced NBM volume and altered microstructural integrity compared to controls.
- Decreased cholinergic cell density correlated with reduced integrity of NBM tracts to the temporal lobe (temporal pole, parahippocampal gyrus).
- Cholinergic cell density was specifically associated with cortical tract alterations in amnestic AD.
Conclusions:
- Cholinergic degeneration in the NBM contributes to damaged cortical projections in AD.
- This damage, particularly to temporal lobe connections, may underlie cognitive decline.
- Findings highlight the role of the NBM-cortical pathway in AD pathophysiology.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment
Role of Neurotransmitters in Memory
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Dementia
The progression of dementia is generally gradual....
Neural Regulation
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

